Real-Time Monitoring of Odorant Receptor Activation in Recombinant Cells
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:52 min • April 28th, 2025
Loading...
Overview
This article describes a method for measuring luminescence in recombinant mammalian cells expressing odorant receptors. The technique involves the use of luciferin and a luminometer to assess the activation of these receptors by odorant molecules.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Pharmacology
Background
- Odorant receptors are crucial for the sense of smell.
- These receptors are coupled with G-proteins and play a role in signal transduction.
- Measuring cyclic AMP levels can indicate receptor activation.
- Luciferin is used as a substrate for luminescence detection.
Purpose of Study
- To develop a reliable method for quantifying the activation of odorant receptors.
- To utilize luminescence as a readout for cellular signaling events.
- To enhance understanding of olfactory receptor function.
Methods Used
- Preparation of adherent recombinant mammalian cells in a stimulation solution.
- Incubation with luciferin to allow cellular uptake.
- Application of odorant solutions and measurement of luminescence using a luminometer.
- Use of cAMP reagents to confirm receptor activation.
Main Results
- Successful activation of odorant receptors was confirmed through luminescence measurement.
- Odorant molecules effectively triggered G-protein signaling pathways.
- The method demonstrated reproducibility and reliability in measuring receptor activity.
- Quantitative data on cyclic AMP levels were obtained.
Conclusions
- The described method provides a robust approach for studying odorant receptor signaling.
- It can be applied to various odorant receptors and signaling pathways.
- This technique may facilitate further research into olfactory mechanisms.
Frequently Asked Questions
What is the role of luciferin in this experiment?
Luciferin serves as a luminescent substrate that allows for the measurement of luminescence when bound to activated glosensor proteins.
How are odorant receptors activated in this study?
Odorant receptors are activated when odorant molecules bind to them, triggering a signaling cascade that leads to increased cyclic AMP levels.
What is the significance of measuring cyclic AMP levels?
Cyclic AMP levels indicate the activation of G-protein coupled receptors, providing insights into cellular signaling mechanisms.
What type of cells are used in this study?
The study uses adherent recombinant mammalian cells that express specific odorant receptors and signaling proteins.
How long is the incubation period for the cAMP reagent?
The cAMP reagent is incubated for two hours at room temperature in a dark and odor-free environment.
What equipment is necessary for this experiment?
A luminometer is required to measure luminescence during the experiment.
Can this method be applied to other types of receptors?
Yes, the method can potentially be adapted to study other G-protein coupled receptors beyond odorant receptors.
Executive Industry Relevance
This method enables quantitative, real-time assessment of G-protein coupled receptor activation in recombinant cells, supporting early-stage target validation in neuroscience and sensory pharmacology. By measuring cAMP-dependent luminescence, it provides a mechanistic readout that aids in de-risking olfactory receptor targets and associated signaling pathways. The approach offers a scalable, reproducible platform for screening odorant-like compounds and evaluating receptor-ligand interactions in a controlled in vitro system.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of odorant receptor function through real-time luminescence readouts linked to G-protein activation and cAMP production.
- Operational Value: Supports functional validation of recombinant receptors in a mammalian cell context, reducing reliance on native tissue preparations.
- Predictive Value: Provides quantitative dose-response data that informs target confidence and prioritization in olfactory target programs.
Screening & Assay Development
- Assay Readiness: Generates standardized, luminescent outputs suitable for high-throughput screening of vapor-phase odorants or volatile compounds.
- Reproducibility: Demonstrates consistent signal detection across wells and measurement cycles, supporting assay robustness.
- Platform Adaptability: Can be configured to study other Gs-coupled receptors by exchanging receptor and biosensor components.
Translational & Preclinical Research
- Translational Alignment: Uses recombinant mammalian cells expressing human odorant receptors, enhancing relevance to human olfactory biology.
- Mechanistic De-risking: Clarifies signaling pathway engagement from ligand binding to second messenger generation.
- Preclinical Continuity: Supports progression from target hit validation to lead optimization by providing mechanistic biomarker data (cAMP).
Pipeline & Workflow Integration
The method fits within the discovery workflow from target engagement screening to lead identification, particularly for GPCR-focused programs in neuroscience and sensory science.
- Discovery Biology: Enables hypothesis testing of odorant receptor ligands and pathway activation in a controlled cellular system.
- Screening: Delivers quantitative, real-time luminescence data that supports compound screening and structure-activity relationship analysis.
- Analytics: Provides cAMP-linked luminescence measurements that allow comparison of agonist potency and efficacy across conditions.
- Translational Research: Uses humanized receptor systems to bridge in vitro findings to physiological olfactory function.
- Enterprise Reuse: Establishes a reusable luminescence-based platform applicable to multiple GPCR targets beyond olfaction.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by linking ligand binding to functional cAMP response.
- Operational Value: Standardizes receptor activation measurement via luminescence, reducing variability across experiments.
- Strategic Value: Improves go/no-go decisions by providing mechanistic, quantitative data on receptor engagement.
- Portfolio Impact: Enables risk-adjusted prioritization of olfactory targets based on functional response profiles.
Implementation Considerations
- Requires expertise in recombinant cell culture, luciferase-based assays, and luminometer operation.
- Dependent on access to a luminometer capable of kinetic luminescence measurement with vapor-phase compound delivery.
- Necessitates standardization of cell expression levels, luciferin loading, and odorant equilibration for reproducible results.
- Adaptation to other receptor systems requires validation of G-protein coupling and biosensor compatibility.
- Limited to receptors that modulate cAMP levels; not directly applicable to Gi-, Gq-, or β-arrestin–biased pathways without biosensor modification.
Biopharma FAQs
Why does luminescence measurement matter for odorant receptor target validation?
Luminescence measurement provides a real-time, quantitative readout of receptor activation by detecting cAMP-dependent conformational changes in Glosensor proteins, which correlates with G-protein signaling efficacy.
How does isolating the odorant as an independent variable support discovery pipeline objectives?
Delivering odorant in the vapor phase between wells allows precise control over ligand concentration and exposure time, enabling reproducible dose-response analysis essential for lead identification.
What do quantitative luminescence measurements enable in receptor screening campaigns?
Quantitative luminescence outputs allow comparison of agonist potency and efficacy across compounds, supporting structure-activity relationship modeling and hit prioritization.
Why are replication requirements important for cross-functional collaboration in assay development?
Replicate luminescence measurements across wells and cycles ensure assay robustness and data reliability, which are critical for transferring screening protocols between discovery and preclinical teams.
What statistical analysis capabilities are required before implementing this method in a screening workflow?
The ability to calculate signal-to-noise ratios, Z’ factors, and dose-response curves from luminescence data is necessary to assess assay quality and suitability for compound screening.
10:16
Perforated Patch-clamp Recording of Mouse Olfactory Sensory Neurons in Intact Neuroepithelium: Functional Analysis of Neurons Expressing an Identified Odorant Receptor
Related Videos
0 Views
09:11
Live-cell Measurement of Odorant Receptor Activation Using a Real-time cAMP Assay
Related Videos
0 Views
09:30
Localization of Odorant Receptor Genes in Locust Antennae by RNA In Situ Hybridization
Related Videos
0 Views
04:55
Assaying Surface Expression of Chemosensory Receptors in Heterologous Cells
Related Videos
0 Views
08:08
Odorant-induced Responses Recorded from Olfactory Receptor Neurons using the Suction Pipette Technique
Related Videos
0 Views
03:30
Measuring Odorant Receptor Activation using a Real-Time Cyclic Adenosine Monophosphate Assay
Related Videos
0 Views
12:02
High-throughput Analysis of Mammalian Olfactory Receptors: Measurement of Receptor Activation via Luciferase Activity
Related Videos
0 Views
15:13
High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy
Related Videos
0 Views
06:49
Tracking Drosophila Larval Behavior in Response to Optogenetic Stimulation of Olfactory Neurons
Related Videos
0 Views
09:53
Real-time In Vitro Monitoring of Odorant Receptor Activation by an Odorant in the Vapor Phase
Related Videos
0 Views
Last updated: 1 August 2026